6L

PaceMate Announces First-in-Market Collaboration with AliveCor to Offer the Only Remote Cardiac Remote Monitoring Platform to Encompass Consumer ECG, Event Monitoring, Heart Failure, and Implantable Cardiac Devices

Retrieved on: 
Friday, May 19, 2023
Blood pressure, Data management, Partnership, FHRS, Heart failure, Atrial fibrillation, Physician, API, FACC, ECG, Risk, Arrhythmia, Triage, HIV disease progression rates, Patient, EHR, FAHA, Diagnosis, 6L, AF, FDA, Health, Pacem School, Caregiver, Griffin Hospital, Medical device, Alivecor

SARASOTA, Fla., May 19, 2023 /PRNewswire/ -- PaceMate® announced today its collaboration with AliveCor®, the global leader in FDA-cleared personal electrocardiogram technology and remote patient management solutions for the cardiovascular industry. This collaboration will combine the strengths of PaceMate's world-class cardiac remote monitoring platform, PaceMateLIVE™ – designed to improve clinical, operational, and financial outcomes – with AliveCor's KardiaPro platform to capture and triage ECG data from the AI-enabled, medical-grade six-lead KardiaMobile(R) 6L and single-lead KardiaMobile Card. Through this collaboration, healthcare providers are able to access clinically relevant heart rhythm analyses and actionable reports via PaceMateLIVE to monitor at-risk patients; identify underlying arrhythmias, including atrial fibrillation (AF); and drive improvements to patient care and clinical outcomes. Additionally, healthcare providers can monitor heart failure risk factors, such as weight and blood pressure, for patients with AliveCor through it's Application Programmer Interface (API) with leading consumer health apps.

Key Points: 
  • SARASOTA, Fla., May 19, 2023 /PRNewswire/ -- PaceMate® announced today its collaboration with AliveCor®, the global leader in FDA-cleared personal electrocardiogram technology and remote patient management solutions for the cardiovascular industry.
  • This collaboration will combine the strengths of PaceMate's world-class cardiac remote monitoring platform, PaceMateLIVE™ – designed to improve clinical, operational, and financial outcomes – with AliveCor's KardiaPro platform to capture and triage ECG data from the AI-enabled, medical-grade six-lead KardiaMobile(R) 6L and single-lead KardiaMobile Card.
  • Additionally, healthcare providers can monitor heart failure risk factors, such as weight and blood pressure, for patients with AliveCor through it's Application Programmer Interface (API) with leading consumer health apps.
  • Additionally, connected solutions with monitoring and EHR integrations like PaceMateLIVE can facilitate seamless sharing of secure ECG data to optimize physicians' workflows.

LINEAR SYSTEMS RELEASES LOW-COST, LOW-NOISE LS844 JFET FOR HIGH-PERFORMANCE APPLICATIONS

Retrieved on: 
Wednesday, July 27, 2022
Silicon, Discrete complementary JFETS, 6L, JFET, Time-invariant system, CISS, IDSS, Common mode, Noise, Electronic component, Transformer, Application

FREMONT, Calif., July 27, 2022 /PRNewswire/ -- Linear Systems announces the re-release of the low-noise, low-cost LS844 series dual JFET with immediate large-scale availability and large-volume pricing.

Key Points: 
  • FREMONT, Calif., July 27, 2022 /PRNewswire/ -- Linear Systems announces the re-release of the low-noise, low-cost LS844 series dual JFET with immediate large-scale availability and large-volume pricing.
  • The LS844 is a low-noise Junction Field Effect Transistor (JFET) ideal for precision, high-end audio, sensor and discrete operational amplifier applications.
  • "The release of this high-performance dual JFET at a low price enables design-ins for high-volume production," Linear Systems President Tim McCune said.
  • The re-released LS844 is the latest evolution of a classic dual JFET developed and introduced by Linear Systems over 20 years ago.

GE Healthcare, AliveCor Partnership Aims to Increase Convenience for Patients and Help Reduce Cardiac-Related Hospitalizations by Improving the Quality and Integration of Patient Data

Retrieved on: 
Wednesday, March 16, 2022
Software, Biotechnology, Practice Management, Pharmaceutical, Health, Medical Devices, Data Management, Technology, MUSE, Twitter, 6L, Intelligence, Patient, News, PMID, Partnership, Hospital, IPED, FDA, Multimedia, Risk, Atrial fibrillation, Attention, Cardiac cycle, Compliance, Emergency department, Â, Insight, Environment, Deep learning, GE Healthcare, Stroke, Algorithm, Wireless ambulatory ECG, ECG, Sale, PDF, Palpitations, EMR, HIMSS, Communication, Privacy, CEO, Instagram, Thomas Edison, Death, NYSE, Arrhythmia, Physician, HIPAA, Health, Ectopia, Efficiency, Workflow, Ecosystem, LinkedIn, Medical imaging, Medical device, Pharmaceutical industry, Tachycardia, Facebook, Bradycardia, Alivecor, GE Healthcare, AliveCor, GE HEALTHCARE, ALIVECOR

View the full release here: https://www.businesswire.com/news/home/20220316005427/en/

Key Points: 
  • View the full release here: https://www.businesswire.com/news/home/20220316005427/en/
    Atrial fibrillation, the most common type of treated heart arrhythmia, is associated with a highly elevated risk of stroke.
  • Currently, if the patient chooses to share the remote ECG, a physician sees AliveCor six-lead ECGs on a patients phone in an office visit or a PDF emailed by the patient.
  • GE Healthcare is the $17.7 billion healthcare business of GE (NYSE: GE).
  • AliveCor protects its customers with stringent data security and compliance practices , achieving HIPAA compliance and SOC2 Type 1 and Type 2 attestations.

LiveCare Partners with AliveCor to Launch Enhanced Remote Cardiac Monitoring Solution for Geriatric Patients at Home and in Skilled Nursing Facilities

Retrieved on: 
Tuesday, December 7, 2021
EKG, AI, Patient, QT, Technology, RPM, Caregiver, 6L, Senior, Health care in the United States, Cardiac cycle, ROI, FDA, Atrial fibrillation, Arrhythmia, Cardiology, Ectopia, Remote patient monitoring, Hospital

"Remote geriatric patients will no longer have to struggle with having to sync multiple apps or deal with the hassles of pairing Bluetooth manually.

Key Points: 
  • "Remote geriatric patients will no longer have to struggle with having to sync multiple apps or deal with the hassles of pairing Bluetooth manually.
  • This integration supports our ambition to save lives and keep geriatric patients at home longer while reducing unnecessary hospitalizations."
  • The Link+ by LiveCare is disrupting the traditional remote patients monitoring market with its automated & AI RPM data aggregation technology.
  • During the past 24 months, LiveCare proven to reduce hospitalizations, lower the RPM cost and increase ROI to the provider.

AliveCor Launches AliveCor Labs

Retrieved on: 
Tuesday, October 12, 2021
Risk, Atrial fibrillation, Arrhythmia, Ectopia, Multimedia, FDA, ECG, 6L, Deep learning, Cardiac cycle, Holter, Stroke, CEO, Labs, Solution, Compliance, Acquisition, Decision-making, Patient, Sale, HIPAA, Technology, Medical device

MOUNTAIN VIEW, Calif., Oct. 12, 2021 /PRNewswire/ -- AliveCor , a leading innovator in FDA-cleared personal electrocardiogram (ECG) technology,todayannounced the launch of AliveCor Labs, further establishing the company's footprint in enterprise class clinical workflows.

Key Points: 
  • MOUNTAIN VIEW, Calif., Oct. 12, 2021 /PRNewswire/ -- AliveCor , a leading innovator in FDA-cleared personal electrocardiogram (ECG) technology,todayannounced the launch of AliveCor Labs, further establishing the company's footprint in enterprise class clinical workflows.
  • Starting today, AliveCor Labs offers a full suite of cardiac monitoring services featuring AliveCor's KardiaMobile 6L, the most clinically-validated six-lead personal electrocardiogram device in the world.
  • "AliveCor Labs offers providers a reimbursed means of monitoring cardiac events with the most well-known personal ECG in the world," said Priya Abani, CEO, AliveCor.
  • AliveCor Labs is the trademark under which AliveCor Inc. provides services from CardioLabs.

Monitor Patient Adverse Drug Effects with New-Age Digital Health Tools, Upcoming Webinar Hosted by Xtalks

Retrieved on: 
Friday, September 24, 2021
Adoption, QT, Food, FDA, Patient, Oncology, LLC, 6L, Digital, ECG, Industry, Pharmaceutical industry, Medical imaging

Because certain medications may have potential adverse effects on patients, many healthcare professionals reconsider prescribing them, despite some of these medications having a higher efficacy than their alternatives.

Key Points: 
  • Because certain medications may have potential adverse effects on patients, many healthcare professionals reconsider prescribing them, despite some of these medications having a higher efficacy than their alternatives.
  • In this webinar, speakers from AliveCor and Market Dynamics will discuss how digital health tools are currently being used to enhance personalized medicine through cardiac safety monitoring programs.
  • Register for this webinar to learn how the adoption of digital health tools can improve patient outcomes by providing accurate, personalized, medical-grade data when it matters most.
  • For more information, or to register for this event, visit Monitor Patient Adverse Drug Effects with New-Age Digital Health Tools.

6L Global Makes Massive Headway in the CBD Market

Retrieved on: 
Thursday, October 17, 2019
Market economics), Microeconomics, 6L, Retail, Brand, Business economics

NEW YORK, Oct.17, 2019 /PRNewswire-PRWeb/ -- 6L Global, a worldwide distributor and brand developer, has seen tremendous success in the CBD market, especially with retail stores.

Key Points: 
  • NEW YORK, Oct.17, 2019 /PRNewswire-PRWeb/ -- 6L Global, a worldwide distributor and brand developer, has seen tremendous success in the CBD market, especially with retail stores.
  • The CBD market is expected to hit $20 billion by 2024, and 6L Global has big plans to contribute to that growth by marketing the current partners they are working with and providing them with substantial distribution opportunities.
  • It makes us more excited about the brands we partner with, which in turn gets them excited about the opportunity.
  • 6L Global helps build and launch brands, streamline manufacturing capabilities and distribute products globally by harnessing their extensive network of retailers around the world.

6L Global's New Office Space in Tokyo Expands Their Brand Distribution Network

Retrieved on: 
Saturday, October 12, 2019
Market economics), Microeconomics, 6L, Retail, Brand, Business economics

This will be the second international office space that 6L Global has acquired, including their office in London.

Key Points: 
  • This will be the second international office space that 6L Global has acquired, including their office in London.
  • "We've seen a huge increase in the desire for distribution channels in Tokyo by our customers, especially in the fashion and beauty industry.
  • 6L Global helps build and strengthen brands, streamline manufacturing capabilities and launch products globally by harnessing their extensive network of retailers and distributors around the world.
  • 6L Global is taking on more brands to distribution in Tokyo.